English
Fischer Medical Ventures Q4 Results
- BSE: 524743
- NSE: FISCHER
- ISIN: INE771F01041
- Sector: Chemical Manufacturing
BSE
92.70
-3.90 (-4.04%)
-3.90 (-4.04%)Volume1.22 L
Updated: Fri 7 Nov, 2025 | 15:40:01
NSE
94.28-2.26 (-2.34%)
-2.26 (-2.34%)Volume8.28 L
Updated: Fri 7 Nov, 2025 | 15:51:02
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Fischer Medical Ventures Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 47.15 | 11.81 | 299.29% | 19.02 | 147.96% |
| Depreciation/ Amortization | 0.51 | 0.56 | -8.40% | 0.18 | 180.54% |
| Operating Income | 2.02 | -0.06 | 0.00% | 1.78 | 13.69% |
| Net Income | 1.31 | -0.29 | 0.00% | 2.03 | -35.40% |
| Other Operating Expenses Total | 6.40 | 2.97 | 115.63% | 2.04 | 213.36% |
| Net Income Before Taxes | 1.81 | 0.12 | 1356.75% | 2.20 | -17.59% |
| Total Revenue | 49.17 | 11.75 | 318.56% | 20.79 | 136.49% |
| Selling/ General/ Admin Expenses Total | 0.94 | 0.75 | 25.38% | 0.34 | 176.13% |
| Diluted Normalized EPS | 0.02 | -0.01 | 0.00% | 0.05 | -60.18% |